Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cha

Showing results (371-380 of 384) with videos related to

Pageof 39
Sort By:
Anesthesiology|August 26, 2024
Paravertebral versus Pectoralis-II (Interpectoral and Pectoserratus) Nerve Blocks for Postoperative Analgesia after Nonmastectomy Breast Surgery: A Randomized, Controlled, Observer-masked Noninferiority TrialRodney A Gabriel, Brian P Curran, Matthew W Swisher, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 25, 2016
Impact of paraaortic lymphadenectomy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group study (KROG 13-17)M S Yoon, W Park, S J Huh, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosisWendy J Broom, Matthew Greenway, Ghazaleh Sadri-Vakili, et al.
Yonsei Medical Journal|March 31, 1999
Korean Nationwide Surveillance of Antimicrobial Resistance of bacteria in 1997Y Chong, K Lee, Y J Park, et al.
Human Molecular Genetics|May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosageAlexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
ESMO Open|September 25, 2025
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)S-A Im, K Park, J Koh, et al.
American Journal of Human Genetics|August 6, 2003
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS studyJian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, et al.
BMC Medical Genetics|August 18, 2006
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS studyJian-Liang Li, Michael R Hayden, Simon C Warby, et al.
Physical Review Letters|February 9, 2005
Angular distributions for (3,4)(Lambda)H bound states in the (3,4)He(e,e(')K+) reactionF Dohrmann, A Ahmidouch, C S Armstrong, et al.
Physical Review Letters|July 15, 2003
High resolution spectroscopy of the 12Lambda B hypernucleus produced by the (e,e'K+) reactionT Miyoshi, M Sarsour, L Yuan, et al.
Pageof 39

Showing results (371-380 of 384) with videos related to

Sort By:
Pageof 39
Anesthesiology|August 26, 2024
Paravertebral versus Pectoralis-II (Interpectoral and Pectoserratus) Nerve Blocks for Postoperative Analgesia after Nonmastectomy Breast Surgery: A Randomized, Controlled, Observer-masked Noninferiority TrialRodney A Gabriel, Brian P Curran, Matthew W Swisher, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 25, 2016
Impact of paraaortic lymphadenectomy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group study (KROG 13-17)M S Yoon, W Park, S J Huh, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosisWendy J Broom, Matthew Greenway, Ghazaleh Sadri-Vakili, et al.
Yonsei Medical Journal|March 31, 1999
Korean Nationwide Surveillance of Antimicrobial Resistance of bacteria in 1997Y Chong, K Lee, Y J Park, et al.
Human Molecular Genetics|May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosageAlexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
ESMO Open|September 25, 2025
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)S-A Im, K Park, J Koh, et al.
American Journal of Human Genetics|August 6, 2003
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS studyJian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, et al.
BMC Medical Genetics|August 18, 2006
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS studyJian-Liang Li, Michael R Hayden, Simon C Warby, et al.
Physical Review Letters|February 9, 2005
Angular distributions for (3,4)(Lambda)H bound states in the (3,4)He(e,e(')K+) reactionF Dohrmann, A Ahmidouch, C S Armstrong, et al.
Physical Review Letters|July 15, 2003
High resolution spectroscopy of the 12Lambda B hypernucleus produced by the (e,e'K+) reactionT Miyoshi, M Sarsour, L Yuan, et al.
Pageof 39